TERM ID="NYU_TERM_1" STRING="BCSC properties" FREQUENCY=1 START=840 END=855 LEMMA="BCSC PROPERTY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_2" STRING="BCSC-enriched MCF-7 MS cells" FREQUENCY=1 START=1208 END=1236 LEMMA="BCSC-ENRICHED MCF-7 MS CELL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_3" STRING="BCSCs" FREQUENCY=2 START=145 END=150 LEMMA="BREAST CANCER STEM CELLS" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_4" STRING="BCSCs" FREQUENCY=2 START=436 END=441 LEMMA="BREAST CANCER STEM CELLS" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_5" STRING="Bcl-2" FREQUENCY=1 START=1486 END=1491 LEMMA="BCL-2" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_6" STRING="Breast cancer stem cells" FREQUENCY=1 START=119 END=143 LEMMA="BREAST CANCER STEM CELL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_7" STRING="CD24-/low phenotype" FREQUENCY=1 START=870 END=889 LEMMA="CD24-/LOW PHENOTYPE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_8" STRING="CD44" FREQUENCY=1 START=865 END=869 LEMMA="CD44" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_9" STRING="CSC maintenance" FREQUENCY=1 START=521 END=536 LEMMA="CSC MAINTENANCE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_10" STRING="Gli1" FREQUENCY=1 START=1372 END=1376 LEMMA="GLI1" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_11" STRING="Gli2" FREQUENCY=1 START=1382 END=1386 LEMMA="GLI2" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_12" STRING="Hedgehog" FREQUENCY=1 START=462 END=470 LEMMA="HEDGEHOG" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_13" STRING="Hh" FREQUENCY=2 START=472 END=474 LEMMA="HEDGEHOG" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_14" STRING="Hh" FREQUENCY=2 START=1750 END=1752 LEMMA="HEDGEHOG" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_15" STRING="Hh pathway" FREQUENCY=4 START=639 END=649 LEMMA="HH PATHWAY" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_16" STRING="Hh pathway" FREQUENCY=4 START=1173 END=1183 LEMMA="HH PATHWAY" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_17" STRING="Hh pathway" FREQUENCY=4 START=1342 END=1352 LEMMA="HH PATHWAY" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_18" STRING="Hh pathway" FREQUENCY=4 START=1823 END=1833 LEMMA="HH PATHWAY" LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_19" STRING="Hh signaling activation" FREQUENCY=1 START=1750 END=1773 LEMMA="SIGNALING ACTIVATION HEDGEHOG" LEMMA_FREQUENCY=1 HEAD_TERM="signaling activation" HEAD_LEMMA="SIGNALING ACTIVATION"
TERM ID="NYU_TERM_20" STRING="MCF-7 MS" FREQUENCY=1 START=796 END=804 LEMMA="MCF-7 M" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_21" STRING="MCF-7 MS cells" FREQUENCY=3 START=807 END=821 LEMMA="MCF-7 MS CELL" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_22" STRING="MCF-7 MS cells" FREQUENCY=3 START=1129 END=1143 LEMMA="MCF-7 MS CELL" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_23" STRING="MCF-7 MS cells" FREQUENCY=3 START=1698 END=1712 LEMMA="MCF-7 MS CELL" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_24" STRING="MCF-7 cells" FREQUENCY=1 START=1156 END=1167 LEMMA="MCF-7 CELL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_25" STRING="MCF-7 mammosphere cells" FREQUENCY=1 START=46 END=69 LEMMA="MCF-7 MAMMOSPHERE CELL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_26" STRING="OCT4" FREQUENCY=1 START=910 END=914 LEMMA="OCT4" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_27" STRING="PTCH" FREQUENCY=1 START=1361 END=1365 LEMMA="PTCH" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_28" STRING="SAL" FREQUENCY=4 START=261 END=264 LEMMA="SALINE " LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_29" STRING="SAL" FREQUENCY=4 START=587 END=590 LEMMA="SALINE " LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_30" STRING="SAL" FREQUENCY=4 START=1089 END=1092 LEMMA="SALINE " LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_31" STRING="SAL" FREQUENCY=4 START=1241 END=1244 LEMMA="SALINE " LEMMA_FREQUENCY=4
TERM ID="NYU_TERM_32" STRING="SAL inhibited Hh" FREQUENCY=1 START=1241 END=1257 LEMMA="INHIBITED HH SALINE " LEMMA_FREQUENCY=1 HEAD_TERM="inhibited Hh" HEAD_LEMMA="INHIBITED HH"
TERM ID="NYU_TERM_33" STRING="SAL-induced selective cytotoxicity" FREQUENCY=1 START=1655 END=1689 LEMMA="SAL-INDUCED SELECTIVE CYTOTOXICITY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_34" STRING="SAL-mediated inhibitory effects" FREQUENCY=1 START=1594 END=1625 LEMMA="SAL-MEDIATED INHIBITORY EFFECT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_35" STRING="SMO" FREQUENCY=1 START=1367 END=1370 LEMMA="SMO" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_36" STRING="Salinomycin" FREQUENCY=3 START=248 END=259 LEMMA="SALINOMYCIN" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_37" STRING="Salinomycin" FREQUENCY=3 START=0 END=11 LEMMA="SALINOMYCIN" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_38" STRING="Salinomycin" FREQUENCY=3 START=248 END=259 LEMMA="SALINOMYCIN" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_39" STRING="Shh-induced Hh" FREQUENCY=1 START=1536 END=1550 LEMMA="SHH-INDUCED HH" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_40" STRING="Shh-induced Hh signaling activation" FREQUENCY=1 START=1536 END=1571 LEMMA="SIGNALING ACTIVATION SHH-INDUCED HH" LEMMA_FREQUENCY=1 HEAD_TERM="signaling activation" HEAD_LEMMA="SIGNALING ACTIVATION"
TERM ID="NYU_TERM_41" STRING="ability" FREQUENCY=1 START=962 END=969 LEMMA="ABILITY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_42" STRING="breast CSC-enriched MCF-7 mammospheres" FREQUENCY=1 START=756 END=794 LEMMA="BREAST CSC-ENRICHED MCF-7 MAMMOSPHERE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_43" STRING="breast cancer MCF-7 cells" FREQUENCY=1 START=685 END=710 LEMMA="BREAST CANCER MCF-7 CELL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_44" STRING="carboxylic polyether ionophore" FREQUENCY=1 START=269 END=299 LEMMA="CARBOXYLIC POLYETHER IONOPHORE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_45" STRING="carcinogenesis" FREQUENCY=1 START=541 END=555 LEMMA="CARCINOGENESI" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_46" STRING="critical components" FREQUENCY=1 START=1315 END=1334 LEMMA="CRITICAL COMPONENT" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_47" STRING="critical components of the Hh pathway" FREQUENCY=1 START=1315 END=1352 LEMMA="HH PATHWAY CRITICAL COMPONENT" LEMMA_FREQUENCY=1 HEAD_TERM="critical components" HEAD_LEMMA="CRITICAL COMPONENT"
TERM ID="NYU_TERM_48" STRING="cyclin D1" FREQUENCY=1 START=1512 END=1521 LEMMA="CYCLIN D1" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_49" STRING="differentiation potential" FREQUENCY=1 START=1015 END=1040 LEMMA="DIFFERENTIATION POTENTIAL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_50" STRING="drug target" FREQUENCY=1 START=1872 END=1883 LEMMA="DRUG TARGET" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_51" STRING="essential downstream targets" FREQUENCY=1 START=1440 END=1468 LEMMA="ESSENTIAL DOWNSTREAM TARGET" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_52" STRING="essential downstream targets including C-myc" FREQUENCY=1 START=1440 END=1484 LEMMA="INCLUDING C-MYC ESSENTIAL DOWNSTREAM TARGET" LEMMA_FREQUENCY=1 HEAD_TERM="including C-myc" HEAD_LEMMA="INCLUDING C-MYC"
TERM ID="NYU_TERM_53" STRING="including C-myc" FREQUENCY=1 START=1469 END=1484 LEMMA="INCLUDING C-MYC" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_54" STRING="inhibited Hh" FREQUENCY=1 START=1245 END=1257 LEMMA="INHIBITED HH" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_55" STRING="invasion capabilities" FREQUENCY=1 START=992 END=1013 LEMMA="INVASION CAPABILITY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_56" STRING="metastasis formation" FREQUENCY=1 START=226 END=246 LEMMA="METASTASIS FORMATION" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_57" STRING="molecular mechanisms" FREQUENCY=1 START=376 END=396 LEMMA="MOLECULAR MECHANISM" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_58" STRING="molecular mechanisms underlying SAL-induced cytotoxicity" FREQUENCY=1 START=376 END=432 LEMMA="UNDERLYING SAL-INDUCED CYTOTOXICITY MOLECULAR MECHANISM" LEMMA_FREQUENCY=1 HEAD_TERM="underlying SAL-induced cytotoxicity" HEAD_LEMMA="UNDERLYING SAL-INDUCED CYTOTOXICITY"
TERM ID="NYU_TERM_59" STRING="pathogenesis" FREQUENCY=1 START=1891 END=1903 LEMMA="PATHOGENESI" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_60" STRING="selective breast CSC inhibitor" FREQUENCY=1 START=331 END=361 LEMMA="SELECTIVE BREAST CSC INHIBITOR" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_61" STRING="selective cytotoxicity" FREQUENCY=2 START=20 END=42 LEMMA="SELECTIVE CYTOTOXICITY" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_62" STRING="selective cytotoxicity" FREQUENCY=2 START=1103 END=1125 LEMMA="SELECTIVE CYTOTOXICITY" LEMMA_FREQUENCY=2
TERM ID="NYU_TERM_63" STRING="serum-free medium" FREQUENCY=1 START=728 END=745 LEMMA="SERUM-FREE MEDIUM" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_64" STRING="signaling activation" FREQUENCY=3 START=1258 END=1278 LEMMA="SIGNALING ACTIVATION" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_65" STRING="signaling activation" FREQUENCY=3 START=1551 END=1571 LEMMA="SIGNALING ACTIVATION" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_66" STRING="signaling activation" FREQUENCY=3 START=1753 END=1773 LEMMA="SIGNALING ACTIVATION" LEMMA_FREQUENCY=3
TERM ID="NYU_TERM_67" STRING="signaling pathway" FREQUENCY=1 START=476 END=493 LEMMA="SIGNALING PATHWAY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_68" STRING="signaling pathway Breast cancer stem cells" FREQUENCY=1 START=101 END=143 LEMMA="SIGNALING PATHWAY BREAST CANCER STEM CELL" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_69" STRING="tumor chemoresistance" FREQUENCY=1 START=187 END=208 LEMMA="TUMOR CHEMORESISTANCE" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_70" STRING="tumorigenicity" FREQUENCY=1 START=1053 END=1067 LEMMA="TUMORIGENICITY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_71" STRING="underlying SAL-induced cytotoxicity" FREQUENCY=1 START=397 END=432 LEMMA="UNDERLYING SAL-INDUCED CYTOTOXICITY" LEMMA_FREQUENCY=1
TERM ID="NYU_TERM_72" STRING="xenografted mice" FREQUENCY=1 START=1071 END=1087 LEMMA="XENOGRAFTED MOUSE" LEMMA_FREQUENCY=1
